A Phase 1 Study of the Safety and Tolerability of CTX-10726

Clinical trial NCT07419841 · RECRUITING

Trial details

NCT number: NCT07419841
Sponsor: Compass Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Gastroesophageal Cancer (GC)Hepatocellular Carcinoma (HCC)Endometrial Cancer Renal Cell Carcinoma (RCC)

Start date: 2026-05-28
Primary completion: 2028-04-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.